ScoreWhy is Zhejiang Garden Biopharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.59% and Operating profit at 5.07% over the last 5 years
2
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 423.36 MM
- NET SALES(9M) At CNY 919.5 MM has Grown at 18.29%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
3
With ROE of 9.77%, it has a very attractive valuation with a 2.20 Price to Book Value
- Over the past year, while the stock has generated a return of -15.98%, its profits have risen by 50.1% ; the PEG ratio of the company is 0.5
- At the current price, the company has a high dividend yield of 0.9
4
Below par performance in long term as well as near term
- Along with generating -15.98% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Garden Biopharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Garden Biopharmaceutical Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Zhejiang Garden Biopharmaceutical Co., Ltd.
-8.71%
0.71
34.69%
China Shanghai Composite
15.19%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.59%
EBIT Growth (5y)
5.07%
EBIT to Interest (avg)
19.11
Debt to EBITDA (avg)
0.40
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.24
Tax Ratio
14.10%
Dividend Payout Ratio
20.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.03%
ROE (avg)
12.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.20
EV to EBIT
22.26
EV to EBITDA
15.07
EV to Capital Employed
2.06
EV to Sales
6.24
PEG Ratio
0.45
Dividend Yield
0.85%
ROCE (Latest)
9.25%
ROE (Latest)
9.77%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 423.36 MM
NET SALES(9M)
At CNY 919.5 MM has Grown at 18.29%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
DEBT-EQUITY RATIO
(HY)
Lowest at 0 %
-3What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 102% (YoY
OPERATING PROFIT(Q)
Lowest at CNY 43.56 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 14.48 %
Here's what is working for Zhejiang Garden Biopharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 423.36 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
At CNY 919.5 MM has Grown at 18.29%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Debt-Equity Ratio
Lowest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Zhejiang Garden Biopharmaceutical Co., Ltd.
Operating Profit
Lowest at CNY 43.56 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 14.48 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Raw Material Cost
Grown by 102% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
